1-5 of 5
Jennie Szeto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Response and Safety for Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Neil Bailey, Tori Braun, Megumi Bailey, Tenzin Tsomo, Jennie Szeto, Swathi Namburi, Joanna Fesler, Sonia Glennie, Vanessa Dunleavy, Julia Carolyn Bokma Parker, Gayle Funk, Heidi Hohmann, Chiachun Lu, Jordan Briggs, Krish Patel
Journal: Blood
Blood (2024) 144 (Supplement 1): 3111.
https://doi.org/10.1182/blood-2024-209252
Published: 2024
Journal Articles

Initial Efficacy and Safety of Acalabrutinib Plus RICE in Transplant Eligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Neil Bailey, Tori Braun, Megumi Bailey, Tenzin Tsomo, Jennie Szeto, Sandra Benitez Kruidenier, Vanessa Dunleavy, Joanna Fesler, Gayle Funk, Sonia Glennie, Judson Hall, Julia Parker, Daniel Egan, Raya Mawad, Carol A Dean, Suzan Sullivan, Chia Lu, Heidi Hohmann, Jordan Briggs, Krish Patel
Journal: Blood
Blood (2022) 140 (Supplement 1): 3765–3766.
https://doi.org/10.1182/blood-2022-164823
Published: 2022
Journal Articles

Initial Safety Results from a Phase II Study of Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Neil Bailey, Tenzin Tsomo, Tori Braun, Jennie Szeto, William I. Bensinger, Daniel Egan, Raya Mawad, Livia Hegerova, Gayle Funk, Joanna Fesler, Sonia Glennie, Judson Hall, Vanessa Dunleavy, Heidi Hohmann, Jordan Briggs, Joshua Mark, Megumi Bailey, John M. Pagel, Krish Patel
Journal: Blood
Blood (2021) 138 (Supplement 1): 4554.
https://doi.org/10.1182/blood-2021-148505
Published: 2021
Journal Articles

Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Neil Bailey, MSc, Tenzin Tsomo, BS, Jennie Szeto, BA, William I Bensinger, MD, Daniel Egan, MD, Livia Hegerova, MD, Raya Mawad, MD, Ami Batchelder, PA, Joanna Fesler, ARNP, Heather Holdread, MS,NP, Sonia Glennie, ARNP, Judson Hall, ARNP, Joey Ferry, ARNP, Megumi Bailey, MSc, David Kane, RN, John M. Pagel, MDPhD, Krish Patel, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34.
https://doi.org/10.1182/blood-2020-141074
Published: 2020
Journal Articles

A Single Center Retrospective Study of Real World Relapsed/Refractory DLBCL Patients Eligible for CAR T-Cell Therapy: Patient Characteristics and Outcomes

Neil Bailey, MSc, John M. Pagel, MD PhD, William Bensinger, MD, Livia Hegerova, MD, Raya Mawad, MD, Michael Milder, MD, Jennie Szeto, BA, Ngan Trinh, BS, Tenzin Tsomo, BS, Paul Wisniewski, BS, Clarisse M. Zayas, Krish Patel, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1715.
https://doi.org/10.1182/blood-2018-99-117780
Published: 2018